A detailed history of Morton Capital Management Llc/Ca transactions in Merck & Co., Inc. stock. As of the latest transaction made, Morton Capital Management Llc/Ca holds 7,367 shares of MRK stock, worth $724,470. This represents 0.16% of its overall portfolio holdings.

Number of Shares
7,367
Previous 6,789 8.51%
Holding current value
$724,470
Previous $841 Million 0.46%
% of portfolio
0.16%
Previous 0.2%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

BUY
$111.15 - $128.97 $64,244 - $74,544
578 Added 8.51%
7,367 $837 Million
Q2 2024

Jul 12, 2024

BUY
$123.8 - $132.96 $3,714 - $3,988
30 Added 0.44%
6,789 $841 Million
Q1 2024

Apr 12, 2024

BUY
$113.24 - $131.95 $23,893 - $27,841
211 Added 3.22%
6,759 $892 Million
Q4 2023

Jan 18, 2024

SELL
$100.18 - $109.02 $108,294 - $117,850
-1,081 Reduced 14.17%
6,548 $714 Million
Q3 2023

Dec 05, 2023

BUY
$102.95 - $114.33 $10,295 - $11,433
100 Added 1.33%
7,629 $785 Million
Q2 2023

Dec 05, 2023

BUY
$108.61 - $118.38 $108,610 - $118,380
1,000 Added 15.32%
7,529 $869 Million
Q1 2023

Dec 05, 2023

BUY
$102.94 - $114.86 $411 - $459
4 Added 0.06%
6,529 $695 Million
Q4 2022

Dec 05, 2023

SELL
$87.44 - $112.11 $43,982 - $56,391
-503 Reduced 7.16%
6,525 $724 Million
Q3 2022

Dec 05, 2023

SELL
$84.53 - $94.96 $37,615 - $42,257
-445 Reduced 5.95%
7,028 $605 Million
Q2 2022

Dec 05, 2023

BUY
$83.49 - $94.64 $3,757 - $4,258
45 Added 0.61%
7,473 $681 Million
Q1 2022

Dec 05, 2023

BUY
$73.51 - $82.4 $15,143 - $16,974
206 Added 2.85%
7,428 $609 Million
Q4 2021

Dec 05, 2023

BUY
$72.28 - $90.54 $522,006 - $653,879
7,222 New
7,222 $553 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Morton Capital Management Llc/Ca Portfolio

Follow Morton Capital Management Llc/Ca and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morton Capital Management Llc/Ca, based on Form 13F filings with the SEC.

News

Stay updated on Morton Capital Management Llc/Ca with notifications on news.